Gene Page:CHEK1
概括?
GeneID | 1111 |
Symbol | CHEK1 |
Synonyms | CHK1 |
Description | checkpoint kinase 1 |
Reference | MIM:603078|HGNC:HGNC:1925|ENSEMBL:ENSG00000149554|HPRD:04356|Vega:OTTHUMG00000165853 |
Gene type | protein-coding |
Map location | 11q24.2 |
Pascal p-value | 0.014 |
eGene | Caudate basal ganglia Putamen basal ganglia |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:GWASDB | Genome-wide Association Studies | GWASdb records for schizophrenia | |
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
文学 | High-throughput literature-search | 与精神分裂症关键词共同存在:精神分裂症,精神分裂症 | Click to show details |
Network | 人蛋白蛋白质相互作用网络中核心基因的最短路径距离 | Contribution to shortest path in PPI network: 0.0238 |
第一节遗传学和表观遗传学注释
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs7110899 | 11 | 125642222 | CHEK1 | ENSG00000149554.8 | 1.77565E-8 | 0 | 146098 | gtex_brain_putamen_basal |
RS929978 | 11 | 125642489 | CHEK1 | ENSG00000149554.8 | 3.15941E-8 | 0 | 146365 | gtex_brain_putamen_basal |
RS929977 | 11 | 125642490 | CHEK1 | ENSG00000149554.8 | 4.3768E-8 | 0 | 146366 | gtex_brain_putamen_basal |
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/CHEK1_DE_GTEx.png)
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
DONSON | 0.79 | 0.80 |
C11orf61 | 0.78 | 0.85 |
NR2C1 | 0.77 | 0.82 |
ZNF334 | 0.77 | 0.83 |
NEK1 | 0.77 | 0.81 |
PEX1 | 0.77 | 0.81 |
WDR75 | 0.76 | 0.77 |
OSBPL9 | 0.76 | 0.80 |
LASS5 | 0.76 | 0.76 |
B4GALT4 | 0.76 | 0.79 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
AF347015.31 | -0.64 | -0.73 |
MT-CO2 | -0.63 | -0.73 |
AF347015.27 | -0.63 | -0.71 |
MT-CYB | -0.60 | -0.70 |
AF347015.21 | -0.59 | -0.71 |
AF347015.8 | -0.59 | -0.71 |
IFI27 | -0.59 | -0.67 |
AF347015.33 | -0.59 | -0.69 |
HIGD1B | -0.56 | -0.64 |
AF347015.15 | -0.56 | -0.69 |
Section III. Gene Ontology annotation
Molecular function | 去的术语 | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0000166 | nucleotide binding | IEA | - | |
GO:0005515 | protein binding | 新闻学会 | 16330544|16963448|17157788 |17292828 |
|
GO:0005524 | ATP binding | IEA | - | |
GO:0004674 | 蛋白质丝氨酸/苏氨酸激酶活性 | EXP | 9278512 | |
GO:0004674 | 蛋白质丝氨酸/苏氨酸激酶活性 | IEA | - | |
GO:0016740 | transferase activity | IEA | - | |
Biological process | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0000077 | DNA damage checkpoint | TAS | 9278511 | |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | TAS | 9278511 | |
GO:0000086 | G2/M transition of mitotic cell cycle | IEA | - | |
GO:0007131 | reciprocal meiotic recombination | TAS | 9278511 | |
GO:0006468 | protein amino acid phosphorylation | IEA | - | |
GO:0006281 | DNA repair | IEA | - | |
GO:0006260 | DNA replication | EXP | 12791985 | |
GO:0007049 | cell cycle | IEA | - | |
GO:0008285 | negative regulation of cell proliferation | TAS | 9278511 | |
GO:0007276 | gamete generation | TAS | 9382850 | |
Cellular component | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0000794 | condensed nuclear chromosome | TAS | 9382850 | |
GO:0005634 | nucleus | IEA | - | |
GO:0005654 | nucleoplasm | EXP | 9278512|12399544 | |
GO:0005657 | replication fork | IEA | - | |
GO:0005737 | 细胞质 | IEA | - |
第四节。蛋白质蛋白相互作用注释
Interactors | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
---|---|---|---|---|---|
ATM | AT1 | ATA | ATC | ATD | ATDC | ATE | DKFZp781A0353 | MGC74674 | TEL1 | TELO1 | ataxia telangiectasia mutated | Protein-peptide | BioGRID | 10608806 |
ATR | FRP1 | MEC1 | SCKL | SCKL1 | ataxia telangiectasia and Rad3 related | Protein-peptide | BioGRID | 10608806 |
ATR | FRP1 | MEC1 | SCKL | SCKL1 | ataxia telangiectasia and Rad3 related | ATR与CHEK1(CHK1)相互作用。 | BIND | 15775976 |
BLM | BS | MGC126616 | MGC131618 | MGC131620 | RECQ2 | RECQL2 | RECQL3 | Bloom syndrome | Affinity Capture-Western Co-localization |
BioGRID | 15364958 |
CDC25A | CDC25A2 | cell division cycle 25 homolog A (S. pombe) | Chk1 phosphorylates Cdc25A-b. This interaction was modeled on a demonstrated interaction between human Chk1 and Cdc25A from an unspecified species. | BIND | 15311285 |
CDC25A | CDC25A2 | cell division cycle 25 homolog A (S. pombe) | Chk1 phosphorylates Cdc25A-a. This interaction was modeled on a demonstrated interaction between human Chk1 and Cdc25A from an unspecified species. | BIND | 15311285 |
CDC25A | CDC25A2 | cell division cycle 25 homolog A (S. pombe) | - | HPRD,BioGRID | 12399544 |
CDC25B | - | cell division cycle 25 homolog B (S. pombe) | - | HPRD,BioGRID | 9278511 |
CDC25C | CDC25 | cell division cycle 25 homolog C (S. pombe) | CHEK1 (Chk1) phosphorylates an unspecified isoform of CDC25C. | BIND | 15735702 |
CDC25C | CDC25 | cell division cycle 25 homolog C (S. pombe) | - | HPRD,BioGRID | 9278511 |
CDKN1A | CAP20 | CDKN1 | CIP1 | MDA-6 | P21 | SDI1 | WAF1 | p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Affinity Capture-Western | BioGRID | 11896572 |
CLSPN | CLASPIN | MGC131612 | MGC131613 | MGC131615 | claspin homolog (Xenopus laevis) | - | HPRD,BioGRID | 12766152 |
CSNK2A1 | CK2A1 |CKII | casein kinase 2, alpha 1 polypeptide | Affinity Capture-Western Reconstituted Complex |
BioGRID | 12902976|15225637 |
E2F1 | E2F-1 | RBAP1 | RBBP3 | RBP3 | E2F transcription factor 1 | E2F1 interacts with the Chk1 promoter. | BIND | 11799067 |
E2F4 | E2F-4 | E2F transcription factor 4, p107/p130-binding | E2F4 interacts with the Chk1 promoter region. | BIND | 11799067 |
MSH2 | COCA1 | FCC1 | HNPCC | HNPCC1 | LCFS2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | Affinity Capture-Western | BioGRID | 15647386 |
PRKDC | DNA-PKcs | DNAPK | DNPK1 | HYRC | HYRC1 | XRCC7 | p350 | 蛋白激酶,DNA激活,催化多肽 | Protein-peptide Reconstituted Complex |
BioGRID | 10608806|12756247 |
RAD51 | BRCC5 | HRAD51 | HsRad51 | HsT16930 | RAD51A | RECA | RAD51同源物(RECA同源物,大肠杆菌)(S. cerevisiae) | Chk1 interacts with RAD51. | BIND | 15665856 |
RELA | MGC131774 | NFKB3 | p65 | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | RELA interacts with CHEK1. This interaction was modeled on a demonstrated interaction between human RELA, and CHEK1 from an unspecified species. | BIND | 15775976 |
SFN | YWHAS | stratifin | Affinity Capture-Western | BioGRID | 11896572 |
TIMELESS | FLJ12640 | FLJ20714 | TIM | TIM1 | hTIM | timeless homolog (Drosophila) | Affinity Capture-Western | BioGRID | 15798197 |
TP53 | FLJ92943 |LFS1 |trp53 |p53 | tumor protein p53 | - | HPRD,BioGRID | 11896572 |
TP53BP1 | 53BP1 | FLJ41424 | MGC138366 | p202 | 肿瘤蛋白p53结合蛋白1 | Co-localization | BioGRID | 15364958 |
XIAP | API3 | BIRC4 | ILP1 | MIHA | XLP2 | X-linked inhibitor of apoptosis | Reconstituted Complex | BioGRID | 14759516 |
XRCC5 | FLJ39089 | KARP-1 | KARP1 | KU80 | KUB2 | Ku86 | NFIV | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | Affinity Capture-Western | BioGRID | 12756247 |
XRCC6 | CTC75 | CTCBF | G22P1 | KU70 | ML8 | TLAA | X-ray repair complementing defective repair in Chinese hamster cells 6 | - | HPRD,BioGRID | 12756247 |
V.途径注释
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG CELL CYCLE | 128 | 84 | 该途径中的所有SZGR 2.0基因 |
KEGG P53 SIGNALING PATHWAY | 69 | 45 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA ATM PATHWAY | 20 | 16 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA G2 PATHWAY | 24 | 20 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA RB PATHWAY | 13 | 11 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA ATRBRCA PATHWAY | 21 | 12 | 该途径中的所有SZGR 2.0基因 |
SA G2 AND M PHASES | 8 | 7 | 该途径中的所有SZGR 2.0基因 |
PID FANCONI PATHWAY | 47 | 28 | 该途径中的所有SZGR 2.0基因 |
PID P73PATHWAY | 79 | 59 | 该途径中的所有SZGR 2.0基因 |
PID ATR PATHWAY | 39 | 25 | 该途径中的所有SZGR 2.0基因 |
PID CIRCADIAN PATHWAY | 16 | 15 | 该途径中的所有SZGR 2.0基因 |
PID P53 REGULATION PATHWAY | 59 | 50 | 该途径中的所有SZGR 2.0基因 |
REACTOME SIGNALING BY SCF KIT | 78 | 59 | 该途径中的所有SZGR 2.0基因 |
REACTOME CELL CYCLE | 421 | 253 | 该途径中的所有SZGR 2.0基因 |
REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | 51 | 31 | 该途径中的所有SZGR 2.0基因 |
REACTOME CELL CYCLE CHECKPOINTS | 124 | 70 | 该途径中的所有SZGR 2.0基因 |
REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 38 | 18 | 该途径中的所有SZGR 2.0基因 |
REACTOME G2 M CHECKPOINTS | 45 | 23 | 该途径中的所有SZGR 2.0基因 |
REACTOME G2 M DNA DAMAGE CHECKPOINT | 12 | 8 | 该途径中的所有SZGR 2.0基因 |
SENGUPTA NASOPHARYNGEAL CARCINOMA UP | 294 | 178 | 该途径中的所有SZGR 2.0基因 |
SOTIRIOU BREAST CANCER GRADE 1 VS 3 UP | 151 | 84 | 该途径中的所有SZGR 2.0基因 |
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA DN | 663 | 425 | 该途径中的所有SZGR 2.0基因 |
BASAKI YBX1 TARGETS UP | 290 | 177 | 该途径中的所有SZGR 2.0基因 |
VECCHI GASTRIC CANCER EARLY UP | 430 | 232 | 该途径中的所有SZGR 2.0基因 |
Ginestier乳腺癌20Q13扩增DN | 180 | 101 | 该途径中的所有SZGR 2.0基因 |
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP | 233 | 161 | 该途径中的所有SZGR 2.0基因 |
RHEIN ALL GLUCOCORTICOID THERAPY DN | 362 | 238 | 该途径中的所有SZGR 2.0基因 |
KINSEY TARGETS OF EWSR1 FLII FUSION UP | 1278 | 748 | 该途径中的所有SZGR 2.0基因 |
Graham CML静止与正常静止 | 87 | 45 | 该途径中的所有SZGR 2.0基因 |
GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP | 181 | 101 | 该途径中的所有SZGR 2.0基因 |
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING DN | 87 | 49 | 该途径中的所有SZGR 2.0基因 |
BIDUS METASTASIS UP | 214 | 134 | 该途径中的所有SZGR 2.0基因 |
DODD NASOPHARYNGEAL CARCINOMA DN | 1375 | 806 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP | 633 | 376 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA ANAPLASTIC UP | 722 | 443 | 该途径中的所有SZGR 2.0基因 |
LANDIS ERBB2 BREAST PRENEOPLASTIC UP | 20 | 10 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781 | 1082 | 该途径中的所有SZGR 2.0基因 |
LANDIS ERBB2 BREAST TUMORS 324 UP | 150 | 93 | 该途径中的所有SZGR 2.0基因 |
BERENJENO TRANSFORMED BY RHOA UP | 536 | 340 | 该途径中的所有SZGR 2.0基因 |
MISSIAGLIA REGULATED BY METHYLATION DN | 122 | 67 | 该途径中的所有SZGR 2.0基因 |
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | 800 | 473 | 该途径中的所有SZGR 2.0基因 |
WAKASUGI HAVE ZNF143 BINDING SITES | 58 | 33 | 该途径中的所有SZGR 2.0基因 |
FARMER BREAST CANCER BASAL VS LULMINAL | 330 | 215 | 该途径中的所有SZGR 2.0基因 |
ROSTY CERVICAL CANCER PROLIFERATION CLUSTER | 140 | 73 | 该途径中的所有SZGR 2.0基因 |
PATIL LIVER CANCER | 747 | 453 | 该途径中的所有SZGR 2.0基因 |
PUJANA BREAST CANCER LIT INT NETWORK | 101 | 73 | 该途径中的所有SZGR 2.0基因 |
PUJANA BRCA1 PCC NETWORK | 1652 | 1023 | 该途径中的所有SZGR 2.0基因 |
PUJANA BRCA2 PCC NETWORK | 423 | 265 | 该途径中的所有SZGR 2.0基因 |
PUJANA CHEK2 PCC NETWORK | 779 | 480 | 该途径中的所有SZGR 2.0基因 |
KAUFFMANN MELANOMA RELAPSE UP | 61 | 25 | 该途径中的所有SZGR 2.0基因 |
FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE UP | 167 | 92 | 该途径中的所有SZGR 2.0基因 |
WEI MYCN TARGETS WITH E BOX | 795 | 478 | 该途径中的所有SZGR 2.0基因 |
GARCIA TARGETS OF FLI1 AND DAX1 DN | 176 | 104 | 该途径中的所有SZGR 2.0基因 |
GOTZMANN EPITHELIAL TO MESENCHYMAL TRANSITION UP | 69 | 55 | 该途径中的所有SZGR 2.0基因 |
BENPORATH ES 1 | 379 | 235 | 该途径中的所有SZGR 2.0基因 |
SHIN B CELL LYMPHOMA CLUSTER 8 | 36 | 28 | 该途径中的所有SZGR 2.0基因 |
MORI IMMATURE B LYMPHOCYTE DN | 90 | 55 | 该途径中的所有SZGR 2.0基因 |
KAUFFMANN DNA REPAIR GENES | 230 | 137 | 该途径中的所有SZGR 2.0基因 |
REN BOUND BY E2F | 61 | 40 | 该途径中的所有SZGR 2.0基因 |
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN | 73 | 45 | 该途径中的所有SZGR 2.0基因 |
Nemeth炎症反应LPS DN | 32 | 25 | 该途径中的所有SZGR 2.0基因 |
ALCALAY AML BY NPM1 LOCALIZATION DN | 184 | 132 | 该途径中的所有SZGR 2.0基因 |
MOREAUX MULTIPLE MYELOMA BY TACI DN | 172 | 107 | 该途径中的所有SZGR 2.0基因 |
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP | 314 | 201 | 该途径中的所有SZGR 2.0基因 |
CHUANG OXIDATIVE STRESS RESPONSE DN | 11 | 9 | 该途径中的所有SZGR 2.0基因 |
JACKSON DNMT1 TARGETS UP | 77 | 57 | 该途径中的所有SZGR 2.0基因 |
HEDENFALK BREAST CANCER BRCA1 VS BRCA2 | 163 | 113 | 该途径中的所有SZGR 2.0基因 |
DOUGLAS BMI1 TARGETS UP | 566 | 371 | 该途径中的所有SZGR 2.0基因 |
DOUGLAS BMI1 TARGETS DN | 314 | 188 | 该途径中的所有SZGR 2.0基因 |
MARSON BOUND BY FOXP3 STIMULATED | 1022 | 619 | 该途径中的所有SZGR 2.0基因 |
由Foxp3绑定的Marson未刺激 | 1229 | 713 | 该途径中的所有SZGR 2.0基因 |
MARSON BOUND BY E2F4 UNSTIMULATED | 728 | 415 | 该途径中的所有SZGR 2.0基因 |
FINETTI BREAST CANCER KINOME RED | 16 | 11 | 该途径中的所有SZGR 2.0基因 |
RIZKI TUMOR INVASIVENESS 3D DN | 270 | 181 | 该途径中的所有SZGR 2.0基因 |
FUJII YBX1 TARGETS DN | 202 | 132 | 该途径中的所有SZGR 2.0基因 |
SMID BREAST CANCER BASAL UP | 648 | 398 | 该途径中的所有SZGR 2.0基因 |
ZHANG BREAST CANCER PROGENITORS UP | 425 | 253 | 该途径中的所有SZGR 2.0基因 |
LABBE WNT3A TARGETS DN | 97 | 53 | 该途径中的所有SZGR 2.0基因 |
BLUM RESPONSE TO SALIRASIB DN | 342 | 220 | 该途径中的所有SZGR 2.0基因 |
MUELLER PLURINET | 299 | 189 | 该途径中的所有SZGR 2.0基因 |
FIRESTEIN PROLIFERATION | 175 | 125 | 该途径中的所有SZGR 2.0基因 |
GOLDRATH ANTIGEN RESPONSE | 346 | 192 | 该途径中的所有SZGR 2.0基因 |
CHANG CORE SERUM RESPONSE UP | 212 | 128 | 该途径中的所有SZGR 2.0基因 |
SHEDDEN LUNG CANCER POOR SURVIVAL A6 | 456 | 285 | 该途径中的所有SZGR 2.0基因 |
ZHANG TLX TARGETS 36HR DN | 185 | 116 | 该途径中的所有SZGR 2.0基因 |
ZHANG TLX TARGETS 60HR DN | 277 | 166 | 该途径中的所有SZGR 2.0基因 |
ZHANG TLX TARGETS DN | 89 | 50 | 该途径中的所有SZGR 2.0基因 |
MILI PSEUDOPODIA HAPTOTAXIS UP | 518 | 299 | 该途径中的所有SZGR 2.0基因 |
CROONQUIST IL6 DEPRIVATION DN | 98 | 69 | 该途径中的所有SZGR 2.0基因 |
CROONQUIST NRAS SIGNALING DN | 72 | 47 | 该途径中的所有SZGR 2.0基因 |
开罗肝母细胞瘤上课 | 605 | 377 | 该途径中的所有SZGR 2.0基因 |
WINNEPENNINCKX MELANOMA METASTASIS UP | 162 | 86 | 该途径中的所有SZGR 2.0基因 |
KYNG WERNER SYNDROM AND NORMAL AGING UP | 93 | 62 | 该途径中的所有SZGR 2.0基因 |
WONG EMBRYONIC STEM CELL CORE | 335 | 193 | 该途径中的所有SZGR 2.0基因 |
WU APOPTOSIS BY CDKN1A VIA TP53 | 55 | 31 | 该途径中的所有SZGR 2.0基因 |
DUTERTRE ESTRADIOL RESPONSE 6HR UP | 229 | 149 | 该途径中的所有SZGR 2.0基因 |
DUTERTRE ESTRADIOL RESPONSE 24HR UP | 324 | 193 | 该途径中的所有SZGR 2.0基因 |
PILON KLF1 TARGETS DN | 1972 | 1213 | 该途径中的所有SZGR 2.0基因 |
LINSLEY MIR16 TARGETS | 206 | 127 | 该途径中的所有SZGR 2.0基因 |
LEE BMP2 TARGETS DN | 882 | 538 | 该途径中的所有SZGR 2.0基因 |
KIM TIAL1 TARGETS | 32 | 22 | 该途径中的所有SZGR 2.0基因 |
FEVR CTNNB1 TARGETS DN | 553 | 343 | 该途径中的所有SZGR 2.0基因 |
GOBERT OLIGODENDROCYTE DIFFERENTIATION UP | 570 | 339 | 该途径中的所有SZGR 2.0基因 |
YU BAP1 TARGETS | 29 | 21 | 该途径中的所有SZGR 2.0基因 |
ROESSLER LIVER CANCER METASTASIS UP | 107 | 72 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
miRNA family | Target position | mirna id | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
mir-15/16/195/424/497 | 38 | 45 | 1A,m8 | hsa-miR-15abrain | UAGCAGCACAUAAUGGUUUGUG |
hsa-miR-16brain | uagcagcacguaaauauuggcg | ||||
hsa-miR-15bbrain | UAGCAGCACAUCAUGGUUUACA | ||||
hsa-miR-195SZ | UAGCAGCACAGAAAUAUUGGC | ||||
hsa-miR-424 | CAGCAGCAAUUCAUGUUUUGAA | ||||
hsa-miR-497 | CAGCAGCACACUGUGGUUUGU | ||||
miR-452 | 84 | 90 | m8 | hsa-miR-452 | UguuugcaggaaacugagaC |